Quantum-Si Announces Restricted Stock Unit Grants for New Employees Under Nasdaq Listing Rule 5635(c)(4)
PorAinvest
jueves, 14 de agosto de 2025, 9:35 am ET1 min de lectura
QSI--
The RSUs will vest 25% on September 20, 2026, with the remainder vesting in 12 equal quarterly installments over the next three years, subject to the employee’s continued employment with Quantum-Si. The RSUs are subject to the terms and conditions of the 2023 Inducement Plan and a RSU agreement covering the grant.
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The company's platform enables real-time kinetic-based detection, allowing researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live.
The announcement of the RSU grants underscores Quantum-Si's commitment to attracting and retaining top talent in the proteomics field. The company's innovative technology and strategic focus on protein analysis position it well to continue its growth trajectory.
References:
[1] https://www.morningstar.com/news/business-wire/20250813611402/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635c4
[2] https://ir.quantum-si.com/news-releases/news-release-details/quantum-si-announces-inducement-grants-under-nasdaq-listing-5
[3] https://www.biospace.com/press-releases/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-august-13-2025
Quantum-Si has granted 237,068 restricted stock units (RSUs) to new employees under its 2023 Inducement Equity Incentive Plan. The RSUs vest 25% on September 20, 2026, with the remainder vesting quarterly over three years. The inducement grants are in accordance with Nasdaq Listing Rule 5635(c)(4) and aimed at attracting new talent to the company.
Quantum-Si Incorporated (Nasdaq: QSI) has announced the grant of 237,068 restricted stock units (RSUs) to new employees under its 2023 Inducement Equity Incentive Plan. The RSUs were granted as an inducement material to attract new talent in accordance with Nasdaq Listing Rule 5635(c)(4).The RSUs will vest 25% on September 20, 2026, with the remainder vesting in 12 equal quarterly installments over the next three years, subject to the employee’s continued employment with Quantum-Si. The RSUs are subject to the terms and conditions of the 2023 Inducement Plan and a RSU agreement covering the grant.
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The company's platform enables real-time kinetic-based detection, allowing researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live.
The announcement of the RSU grants underscores Quantum-Si's commitment to attracting and retaining top talent in the proteomics field. The company's innovative technology and strategic focus on protein analysis position it well to continue its growth trajectory.
References:
[1] https://www.morningstar.com/news/business-wire/20250813611402/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635c4
[2] https://ir.quantum-si.com/news-releases/news-release-details/quantum-si-announces-inducement-grants-under-nasdaq-listing-5
[3] https://www.biospace.com/press-releases/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-august-13-2025

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios